key: cord-1011900-8tdrv1ka
authors: Loveday, Emma K.; Hain, Kyle S.; Kochetkova, Irina; Hedges, Jodi F.; Robison, Amanda; Snyder, Deann T.; Brumfield, Susan K.; Young, Mark J.; Jutila, Mark A.; Chang, Connie B.; Taylor, Matthew P.
title: Effects of inactivation method on SARS-CoV-2 virion protein and structure
date: 2020-11-16
journal: bioRxiv
DOI: 10.1101/2020.11.14.383026
sha: 612e92eb662831667de395e57171ed417c74d78a
doc_id: 1011900
cord_uid: 8tdrv1ka

The risk posed by Severe Acute Respiratory Syndrome Coronavirus −2 (SARS-CoV-2) dictates that live-virus research is conducted in a biosafety level 3 (BSL3) facility. Working with SARS-CoV-2 at lower biosafety levels can expedite research yet requires the virus to be fully inactivated. In this study, we validated and compared two protocols for inactivating SARS-CoV-2: heat treatment and ultraviolet irradiation. The two methods were optimized to render the virus completely incapable of infection while limiting destructive effects of inactivation. We observed that 15 minutes of incubation at 65°C completely inactivates high titer viral stocks. Complete inactivation was also achieved with minimal amounts of UV power (70,000 μJ/cm2), which is 100-fold less power than comparable studies. Once validated, the two methods were then compared for viral RNA quantification, virion purification, and antibody recognition. We observed that UV irradiation resulted in a 2-log reduction of detectable genomes compared to heat inactivation. Protein yield following virion enrichment was equivalent for all inactivation conditions, but the resulting viral proteins and virions were negatively impacted by inactivation method and time. We outline the strengths and weaknesses of each method so that investigators might choose the one which best meets their research goals.

the virus to be fully inactivated. In this study, we validated and compared two protocols 23 for inactivating SARS-CoV-2: heat treatment and ultraviolet irradiation. The two 24 methods were optimized to render the virus completely incapable of infection while 25 limiting destructive effects of inactivation. We observed that 15 minutes of incubation at 26 65˚C completely inactivates high titer viral stocks. Complete inactivation was also 27 achieved with minimal amounts of UV power (70,000 µJ/cm2), which is 100-fold less 28 power than comparable studies. Once validated, the two methods were then compared 29 for viral RNA quantification, virion purification, and antibody recognition. We observed 30 that UV irradiation resulted in a 2-log reduction of detectable genomes compared to 31 heat inactivation. Protein yield following virion enrichment was equivalent for all 32 inactivation conditions, but the resulting viral proteins and virions were negatively 33 impacted by inactivation method and time. We outline the strengths and weaknesses of 34 each method so that investigators might choose the one which best meets their 35 research goals. 36

The emergence of the novel SARS-CoV-2 resulted in tremendous social and 39 economic distress. Factors affecting the outcome of SARS-CoV-2 infection remain 40 unclear, meriting considerable research investment. Research with infectious SARS-41

CoV-2 must be performed under biosafety level 3 (BSL3) conditions. While these 42 conditions excel at keeping researchers and the community safe, they lack the 43 expediency required for responding to a global pandemic. Researching SARS-CoV-2 at 44 a more accessible, lower biosafety level requires that the virus first be rendered non-45 infectious [1] . Several effective methods have been devised to inactivate SARS-CoV-2, 46 but unfortunately many of these techniques destroy the structural and genetic properties 47 transcribed RNA, gBlocks were ordered from IDT with a T7 promoter, forward and 107 reverse primer sites, and probe sequence for the RdRp (Orf1ab) gene and E gene of 108 

Suspensions of purified virions were coated onto 96-well ELISA plates at 4ug total 141 protein per ml in PBS (50ul per well) and incubated at 4 degrees C overnight. Excess 142 protein was decanted and plates washed five times with 0.1% Tween-20 in PBS (wash 143 buffer). Plates were blocked with 3% nonfat milk in wash buffer for 1 hour. Mid-titer 144 rabbit polyclonal serum obtained from BEI Resources (Manassas, VA) was 2-fold 145 serially diluted in 1% nonfat milk in wash buffer, applied to plates, and incubated for 2 146 hours. Antisera was decanted and plates were washed as above, followed by 147 incubation for 1 hour at room temperature with a 1:3000 dilution of goat-anti-rabbit 148 secondary antibody conjugated to HRP in wash buffer with 1% nonfat milk. The extent 149 of antibody capture was measured by colorimetric detection following treatment with 150 TMB substrate and acid stop solution and quantified on a Molecular Devises 151

VERSAMax microplate reader.

Inactivation of SARS-CoV-2 by exposure to elevated temperature 154

The first method of inactivation we employed was the well-established procedure of 155 incubation at high temperature [2, 8] . Viral supernatants were incubated in a water bath 156 at 65˚C for specific intervals of time. The principle of this method is that excessive heat 157 destabilizes viral proteins and assemblies, rendering them incapable of infection. 158

To test this inactivation method, a time course of heat exposure was conducted 159 in screw-cap tubes containing 1.4 mL of SARS-CoV-2 viral stocks. The water bath was 160 pre-heated for one hour with the temperature confirmed by an external thermometer. 161

The tubes were placed into the water bath and held for 15, 20, 25, or 30 minutes. At 162 each time point three tubes were removed from the water bath and placed onto chilled 163 beads to reduce temperature and prevent excessive inactivation. Samples were then 164 subjected to limiting dilution and assessed by plaque assay, as detailed in Table 1 . Our 165 calculated titer at 0 minutes was 1.04 × 10 8 pfu/mL. Plaque assays performed on 166 clarified viral supernatant heated at 65°C for 15, 20, 25 and 30 minutes resulted in zero 167 countable plaques (Table 1 ). This data demonstrates that a complete loss of viral 168 infectivity was observed following heat inactivation for all time points tested after T0. 169

To test the inactivation ability of UV-C, a time course of UV exposure was employed to 171 determine the minimal amount of UV irradiation required to inactivate SARS-CoV-2 172 [4, 9] . Up to 15 mL of clarified viral supernatant was placed in a 10cm Petri dish without 173 a lid and exposed to UV-C irradiation for various amounts of time, as described in the 174 Materials and Methods. UV-C treated virus was then subjected to limiting dilution and assessed by plaque assay. Initial testing looked at the inactivation of SARS-CoV-2 176 following 15s, 30s, 45s, 1 min, 2 min, 3min, and 4 min of UV-C exposure. The 177 calculated titer of unexposed viral stocks was 4.5 × 10 7 pfu/mL. We observed no viral 178 plaques at all UV-C exposure times. We therefore evaluated SARS-CoV-2 inactivation 179 following 2s, 5s, 10s, and 15s of UV-C exposure. The titer of unexposed stocks was 180 1.04 × 10 8 pfu/mL. Plaques were detected following 2s and 5s exposure, correlating to 181 1.39 × 10 5 pfu/mL and 10 pfu/mL, a 3-and 7-log reduction in infectivity, respectively. 182

Exposures of 10s or greater resulted in no detectable plaques demonstrating a 183 complete loss of virus infectivity (Table 2, Figure 1 ). 184

A common method of assessing efficacy of inactivation for UV-C irradiation is to 186 calculate a sterility assurance level [10]. The SAL is a standard used to estimate the 187 probability of a single viable pathogen being present in a sample following inactivation. The reduction in titer following 2 and 5 seconds of UV-C exposure leads to the 198 calculated dose needed to inactivate one log of SARS-CoV-2, which is 5,320 µJ/cm 2 199 delivered by the UV sterilizer. Using this D10 value means that to reduce infectious titer and only 3.9 × 10 3 genome copies with the RdRp and E primers, respectively. The 231 genomic location of the RdRp and E genes, along with the increased variability in 232 detection via qRT-PCR, suggests that degradation of the RNA may be proceeding from 233 the 3' end of the genome following exposure to UV-C radiation. In contrast, heat 234 inactivation at T20 and T25 resulted in an average of 1.2 × 10 8 genome copies per µl 235 and at T30 an average of 1.6 × 10 8 genome copies per µl with the RdRp primers. The E 236 primers detected an average of 2.6 × 10 7 , 3.6 × 10 7 , and 2.7 × 10 7 genome copies per µl 237 from viral stocks heat inactivated for 20, 25, and 30 minutes, respectively. Compared to 238 UV treatment, heat inactivation did not disrupt the SARS-CoV-2 genome allowing for 239 comparable amounts of RNA detected compared to untreated controls. Overall, the E 240 primers resulted in slightly lower amount of RNA detected, which could be the result of 241 degradation from the 3' end of the genome and should be considered when designing 242

qRT-PCR assays for use with heat inactivated samples.

To remove contaminates from inactivated virions, we employed a two-step 245 sucrose gradient purification previously described for the porcine epidemic diarrhea cleaved portions of the Spike. Additionally, we observed that greater UV exposure produced a minor, but detectable, amount of slower migrating N-protein that was not 267 detected at 1 minute of UV exposure. 268

To better understand the state of the virion following inactivation and purification, 

Retaining the antigenicity of inactivated virus is an important consideration when 279 developing diagnostic assays or vaccines. To this end, we assessed the serological 280 detectability of our inactivated viruses using an indirect ELISA. Wells were coated with 281 equivalent amounts of viral protein prior to being exposed to a dilution series of SARS-282

CoV-2-specific poly-clonal rabbit serum. Negative control rabbit serum was used to 283 measure the background binding capacity of the different preparations. As depicted in 284 Figure 5 , all purified virion preparations had marginal background signal from the 285 negative control serum. We observed that detection of virion components was 286 influenced by the type and extent of inactivation. Optimal detection was observed for 287 samples receiving 1-or 5-minutes of UV-C irradiation, with no signal detected from the 288 10-minute sample. Heat inactivated material was also detected, but at a lower rate than that of UV-C inactivated samples. Together, this suggests that short duration UV 290 exposure produces the higher quality of virions compared to heat inactivation. 291

Viral inactivation is a powerful tool for mitigating research risk while expediting scientific 293 objectives. The most useful methods of inactivation are effective and reliable without 294 being overly destructive to virion components. The goal of this study was to validate two 295 methods of SARS-CoV-2 inactivation-heat inactivation and UV-C irradiation-and 296 assess their respective effects on virion components. We observed that both techniques 297

were wholly effective at inactivating virus with minimal effects on virion morphology and 298 antibody mediated detection. 299

An important initial aspect of this study was to determine the appropriate levels of viral 300 inactivation by both methods. Insufficient inactivation puts researchers at risk for 301 exposure, while excessive inactivation can compromise important virion components 302 and limit research applicability. In this study, we observed that excessive UV-C 303 irradiation reduced SARS-CoV-2 detection by ELISA, likely due to significant cross-304

linking of viral proteins observed by Western Blot. Many studies published on the 305 inactivation of beta-coronaviruses use significantly higher levels of UV-C irradiation than 306 what we report here [4,9,13]. Our methods significantly reduced UV-C exposure by 307 optimizing experimental conditions. Working in a biosafety cabinet, we removed the 308 plastic lids from the 10cm dishes that would have otherwise absorbed much of the 309

incoming UV-C radiation. Because UV-C is attenuated as a function of depth, we also 310 enhanced the surface area of exposure while limiting the fluid depth to less than 2mm, 311 ensuring equal inactivation of the sample throughout and limiting overexposure. In a similar vein, heat inactivation was performed in small volume tubes (1.5 mL) in a water 313 bath to ensure the even heating and inactivation of samples throughout. The results of our study indicate that both heat inactivation and UV-C irradiation are 333 viable methods for inactivating SARS-CoV-2 for use in BSL-2 laboratory environments. 334

Both methods left the virion mostly intact while effects on other viral properties differed. Viral supernatants inactivated by UV or Heat exposure were loaded onto a two-step 415 sucrose gradient and subjected to ultracentrifugation. The resulting pellets were 416 resuspended in PBS and analyzed for protein content. A) 5 µg of resuspended pellets 417 from the two inactivation conditions were loaded onto a 10% SDS-PAGE gel that was 418 then subjected to Coomassie staining. B) 0.2 µg of each pellet was run on a 10% gel 419 and transferred to PVDF membrane for Western analysis for SARS-CoV-2 Spike or 420

Nucleocapsid. Protein extracted from SARS-CoV-2 infected cells was run as a positive 421 control. 422 Semi-purified virions from both UV and Heat inactivated methods were used as coating 430 antigen in an indirect ELISA assay. Poly-clonal serum from negative control or SARS-431

CoV-2 Spike immunized rabbits was used as the primary antibody with anti-rabbit-HRP 432 and colorimetric detection was used to measure the extent of antibody capture. Plotted 433 is the resulting O.D. measurements from a representative set of dilutions. 434

Propagation, Inactivation, and Safety Testing 357 of SARS-CoV-2. Viruses

Heat Inactivation of Different Types of 359

SARS-CoV-2 Samples: What Protocols for Biosafety

Serological Diagnostics? Viruses 2020

Using heat to kill SARS-CoV-2

Susceptibility of SARS-CoV-2 to UV Irradiation

Use of Methyl Cellulose Gel as a Substitute for Agar in Tissue-366

Detection of novel 368 coronavirus (2019-nCoV) by real-time RT-PCR

Enzyme-linked immunosorbent assay for the detection of 370 porcine epidemic diarrhea coronavirus antibodies in swine sera

Effects of Different Temperature and Time Durations of Virus Inactivation on Results of 374

Real-time Fluorescence PCR Testing of COVID-19 Viruses

Inactivation of the 377 coronavirus that induces severe acute respiratory syndrome, SARS-CoV

The limits of sterility assurance

The impacts of viral inactivating methods on 382 quantitative RT-PCR for COVID-19

Supramolecular Architecture of Severe 385

Acute Respiratory Syndrome Coronavirus Revealed by Electron Cryomicroscopy

Coronavirus Virions for Vaccine Antigen

Laboratory Protocols